Pharma Trek | IAP- Immunisation Chart

"IAP Immunization Timetable 2012"

I. IAP recommended vaccines for routine use

Age (completed weeks/months/years)	Vaccines	Comments
Birth	BCG OPV 0 Hep-B 1	Hepatitis-B : Administer Hep-B vaccine to all newborns before hospital discharge
6 weeks	DTwP 1/DTaP 1 IPV 1 Hep-B 2 Hib 1 Rotavirus 1	Polio: All doses of IPV may be replaced with OPV if former is unaffordable/unavailable Additional doses of OPV on all supplementary immunization activities (SIAs) Two doses IPV instead of 3 for primary series if started at 8 weeks, and 8 weeks interval between the doses Rotavirus: 2 doses of RV-1 and 3 doses of RV-5
10 weeks	DTwP 2/DTaP 2 IPV 2 Hib 2 Rotavirus 2 PCV 2
14 weeks	DTwP 3/DTaP 3 IPV 3 Hib 3 Rotavirus 3 PCV 3	Rotavirus: Only 2 doses of RV1 are recommended at present.
6 months	OPV 1 Hep-B 3	Hepatitis-B: The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose.
9 months	OPV 2 Measles
12 months	Hep-A 1	Hepatitis A: For both killed and live hepatitis-A vaccines, 2 doses are recommended
15 months	MMR 1 Varicella 1 PCV booster	Varicella: The risk of breakthrough varicella is lower if given 15 months onwards.
16 to 18 months	DTwP B1/DTaP B1 IPV B1 Hib B1	The first booster (4thth dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose.
18 months	Hep-A 2	Hepatitis A: For both killed and live hepatitis-A vaccines 2 doses are recommended
2 years	Typhoid 1	Typhoid: Typhoid revaccination every 3 years, if Vipolysaccharide vaccine is used.
4 ½ to 5 years	DTwP B2/DTaP B2 OPV 3 MMR 2 Varicella 2 Typhoid 2	MMR: the 2nd dose can be given at anytime 4-8 weeks after the 1st dose. Varicella: the 2nd dose can be given at anytime 3 months after the 1st dose.
10 to 12 years	Tdap/Td HPV	Tdap: is preferred to Td followed by Td every 10 years. HPV: Only for females, 3 doses at 0, 1-2 (depending on brands) and 6 months.

II. IAP recommended vaccines for High-risk* children (Vaccines under special circumstances):

Influenza Vaccine
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Cholera Vaccine
Rabies Vaccine
Yellow Fever Vaccine
Pneumococcal Polysaccharide vaccine (PPSV 23)

* High-risk category of children:

Congenital or acquired immunodeficiency (including HIV infection),
Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), liver disease and diabetes mellitus
Children on long term steroids, salicylates, immunosuppressive or radiation therapy
Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
Children with functional/ anatomic asplenia/ hyposplenia
During disease outbreaks
Laboratory personnel and healthcare workers
Travelers

Immunisation Schedule – 2011

Age	Vaccines	Note
Birth	BCG OPV zero Hepatitis B -1	- - -
6 weeks	OPV-1 + IPV-1 / OPV -1 DTPw-1 / DTPa -1 Hepatitis B -2 Hib -1	OPV alone if IPV cannot be given - - -
10 weeks	OPV-2 + IPV-2 / OPV-2 DTPw-2 / DTPa -2 Hib -2	OPV alone if IPV cannot be given - -
14 weeks	OPV-3 + IPV-3 / OPV -3 DTPw-3 / DTPa -3 Hepatitis B -3 Hib -3	OPV alone if IPV cannot be given - Third dose of Hepatitis B can be given at 6 months of age -
9 months	Measles
15-18 months	OPV-4 + IPV-B1 / OPV -4 DTPw booster -1 or DTPa booster -1 Hib booster MMR -1	OPV alone if IPV cannot be given - - -
2 years	Typhoid	Revaccination every 3-4 years
5 years	OPV -5 DTPw booster -2 or DTPa booster -2 MMR -2	- - The second dose of MMR vaccine can be given at any time 8 weeks after the first dose
10 years	Tdap HPV	- Only girls, three doses at 0, 1-2 and 6 months
	Vaccines that can be given after discussion with parents
More than 6 weeks	Pneumococcal conjugate	3 primary doses at 6, 10, and 14 weeks, followed by a booster at 15-18 months
More than 6 weeks	Rotaviral vaccines	(2/3 doses (depending on brand) at 4-8 weeks interval
After 15 months	Varicella	Age less than 13 years: one dose Age more than 13 years: 2 doses at 4-8 weeks interval
After 18 months	Hepatitis A	2 doses at 6-12 months interval

The IAP endorses the continued use of whole cell pertussis vaccine because of its proven efficacy and safety. Acellular pertussis vaccines may undoubtedly have fewer side-effects (like fever, local reactions at injection site and irritability), but this minor advantage does not justify the inordinate cost involved in the routine use of this vaccine.
If the mother is known to be HBsAg negative, HB vaccine can be given along with DTP at 6, 10, 14 weeks/ 6 months. If the mother's HBsAg status is not known, it is advisable to start vaccination soon after birth to prevent perinatal transmission of the disease. If the mother is HBsAg positive (and especially HBeAg positive), the baby should be given Hepatitis B Immune Globulin (HBIG) within 24 hours of birth, along with HB vaccine.
Varicella, Hepatitis A and Pneumococcal Conjugate vaccines should be offered only after one to one discussion with parents. Also refer to the individual vaccines notes for recommendations.
Combination vaccines can be used to decrease the number of pricks being given to the baby and to decrease the number of clinic visits. The manufacturer's instructions should be followed strictly whenever "mixing" vaccines in the same syringe prior to injection.
At present, the only typhoid vaccine available in our country is the Vi polysaccharide vaccine. Revaccination may be carried out every 3- 4 years.
Under special circumstances (e.g. epidemics), measles vaccine may be given earlier than 9 months followed by MMR at 12-15 months.
During pregnancy, the interval between the two doses of TT should be at least one month.
We should continue to use OPV till we achieve polio eradication in India. IPV can be used additionally for individual protection.
OPV must be given to children less than 5 years of age at the time of each supplementary immunisation activity.